IRCT20200404046932N1招募中2 期
Efficacy evaluation of FLUVAR® in the onset of the disease with symptoms of respiratory infection synonymous with the symptoms of COVID-19 in patients referred to emergency departments and clinics
Hakiman e Shargh Research Co.0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age 18 years and older
- •Signing informed consent
- •Possessing two distinct respiratory signs of COVID-19
- •O2Sat below 94% or positive signs on CT scan or positive PCR result for COVID-19
排除标准
- •History of moderate or severe respiratory asthma
- •Participating in another clinical trial for COVID-19
研究者
相似试验
进行中（未招募）
1 期
Study of the Efficacy of FLU-v against Influenza infectioInfluenza virusMedDRA version: 19.0 Level: PT Classification code 10022000 Term: Influenza System Organ Class: 10021881 - Infections and infestationsEUCTR2016-002134-74-GBPepTcell Limited (trade name SEEK)153
已完成
2 期
Compairing two drugs(Vatari Guggulu and Pottali Sweda (Karpasathyadi Churna )In Low Back PaiCTRI/2022/09/045805State Ayurvedic College and Hospital Lucknow49
招募中
3 期
The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19IRCT20200506047323N3Bandare-abbas University of Medical Sciences60
进行中（未招募）
1 期
A phase I study of FLOT in metastatic gastric cancerGastric cancerJPRN-jRCTs041200044Masuishi Toshiki36
已完成
不适用
Pilot Study of efficacy and safety of nalfurafine hydrochloride for jaundice associated pruritusPruritusJPRN-UMIN000033255Wakayama Medical University12